RTW Investments logo

RTW Investments

North America, New York, United States, New York

Description

RTW Investments makes investments in forward-thinking healthcare companies.

Investor Profile

RTW Investments has made 115 investments, with 22 in the past 12 months and 27% as lead.

Stage Focus

  • Post Ipo Equity (31%)
  • Series B (27%)
  • Series C (16%)
  • Series A (10%)
  • Series D (9%)
  • Private Equity (3%)
  • Undisclosed (1%)
  • Series G (1%)
  • Post Ipo Debt (1%)
  • Series Unknown (1%)

Country Focus

  • United States (78%)
  • United Kingdom (5%)
  • Switzerland (4%)
  • China (3%)
  • Canada (3%)
  • Germany (2%)
  • Ireland (2%)
  • The Netherlands (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Biopharma
  • Medical Device
  • Genetics
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does RTW Investments frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 14
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 15
CA
North America, Massachusetts, United States, Boston
Co-Investments: 21
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 13
Venrock Healthcare Capital Partners
North America, California, United States, Palo Alto
Co-Investments: 17
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 25
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 32
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 16
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 21
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 17

Which angels does RTW Investments often collaborate with?

SK
North America, California, United States, Los Angeles
Shared Deals: 1
RK
North America, California, United States, Los Angeles
Shared Deals: 1
CG
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by RTW Investments?

Tenax Therapeutics

Chapel Hill, North Carolina, United States

Tenax Therapeutics focuses on identifying and developing treatments that address cardiovascular and pulmonary diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityMar 5, 2025
Amount Raised: $25,000,000
Umoja Biopharma

Seattle, Washington, United States

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

BiopharmaBiotechnologyDeveloper Platform
Series CJan 14, 2025
Amount Raised: $100,000,000
Allurion Technologies

Wellesley, Massachusetts, United States

Allurion Technologies develops a medical device for weight loss that can be delivered and removed without surgery or endoscopy.

Health CareMedical DeviceTherapeutics
Post Ipo EquityJan 14, 2025
Amount Raised: $2,500,000
Windward Bio

Basel, Basel-Stadt, Switzerland

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

BiotechnologyLife ScienceMedical
Series AJan 10, 2025
Amount Raised: $200,000,000
Numab

Wadenswil, Zurich, Switzerland

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsLife ScienceMedicalTherapeutics
Series CJan 9, 2025
Amount Raised: $54,939,501
Alesta Therapeutics

Leiden, Zuid-Holland, The Netherlands

Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.

Biotechnology
Series AJan 8, 2025
Amount Raised: $67,301,858
Ikena Oncology

Boston, Massachusetts, United States

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics
Post Ipo EquityDec 23, 2024
Amount Raised: $75,000,000
Rapt Therapeutics

South San Francisco, California, United States

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityDec 23, 2024
Amount Raised: $150,000,000

Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.

BiotechnologyHealth CarePharmaceutical
Series ADec 19, 2024
Amount Raised: $140,000,000
Beta Bionics

Irvine, California, United States

Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.

BiotechnologyDiabetesMedical Device
Series ENov 13, 2024
Amount Raised: $60,000,000